Home Global Health Policy Topics

Global Health Policy

New and Noteworthy

The Trump Administration’s Latest Expansion of the Mexico City Policy: A Funding Analysis

On Friday, January 23, 2026, the Trump administration released the latest expansion of the Mexico City Policy (MCP). The controversial policy, which had restricted foreign non-governmental organizations (NGOs) from performing or promoting abortion as a method of family planning as a condition of receiving most U.S. global health aid, has been broadened significantly to include more organizations (not just foreign NGOs) and most U.S. foreign aid. Also, the policy now prohibits activities related to diversity, equity, and inclusion (DEI) as well as support for gender-affirming care and services, and legal protections based on gender identity (among other activities). This move marks the most significant expansion of the MCP in more than 40 years — extending its reach far beyond the policy’s expansion during Trump’s first term.

This analysis assesses the potential reach of the latest expansion of the Mexico City Policy, which is now part of the Promoting Human Flourishing in Foreign Assistance (PHFFA) Policy.

The Mexico City Policy: An Explainer

Questions for the America First Global Health Strategy

Global Health Budget Summaries

Overview of President Trump’s Executive Actions on Global Health

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials

Global Health Trackers

U.S. Global Health Budget Tracker

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Global Health Policy

Filter

List Grid

501 - 510 of 640 Results

  • Historical Trends in U.S. Funding for Global Health

    Issue Brief

    To provide context for the release of the administration’s first, full budget request for FY 2022, this brief provides an overview of historical trends in U.S. global health funding, including changes in program-specific funding over time, the distribution between bilateral and multilateral support, and in the increasing use of emergency supplemental funding in response to outbreaks.

  • Funding for Key HIV Commodities in PEPFAR Countries

    Issue Brief

    In many low- and middle-income countries, PEPFAR and the Global Fund are significant funders of commodities to diagnose, treat, and prevent HIV, along with country governments. But, information on their relative contributions, which is important for assessing the HIV response, is not readily available. We analyzed data from PEPFAR documents on funding for key HIV commodities in 34 PEPFAR countries to better understand the funding landscape.

  • U.S. Global Health Budget Tracker

    Feature

    This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

  • Donor Government Funding for Family Planning in 2019

    Report

    Donor government support for global family planning efforts totaled US$1.50 billion in 2018, up 19% from 2017 (US$1.26 billion) – and the highest level since tracking efforts began following the London Summit on Family Planning in 2012.

  • The U.S. Global Health Budget: Analysis of Appropriations for Fiscal Year 2016

    Issue Brief

    After Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.

  • Zika Virus: The Challenge for Women

    News Release

    In the latest post in the Policy Insights series, Jen Kates, Josh Michaud, and Allison Valentine examine how rapid emergence of Zika virus in the Americas, and its association with a severe birth defect, impact women as some health officials are calling for women to avoid pregnancy even though they have limited reproductive health access…

  • Zika Virus: The Challenge for Women

    Perspective

    In the latest post in the Policy Insights series, Jen Kates, Josh Michaud, and Allison Valentine examine how rapid emergence of Zika virus in the Americas, and its association with a severe birth defect, impact women as some health officials are calling for women to avoid pregnancy even though they have limited reproductive health access in some of the affected countries. They also examine the role of the U.S. government in addressing Zika and its impact on women in Latin America and the Caribbean.

  • Web Briefing for Media – The Zika Virus: What’s Next in the U.S. and Abroad?

    Event Date:
    Event

    The rapid spread of the Zika virus in the Latin America and the Caribbean region, the appearances of cases of Zika in the United States, and the association between Zika infection and serious birth defects has generated attention and concern among the public, policymakers, and the media.